Don't think the market will respond well to this announcement imo.
Personally, I'm very happy with the Phase I trial results. Phase II trials will be very important, but as Dr Aston mentioned in the Ann, the combination of PPL-1 with other Chemo drugs will be the company maker imo...
GLTA
Ann: Clinical Trial Report Following Phase I Trial, page-2
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $5.307K | 28.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 551793 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 25917 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |